DRUG DELIVERY - Peeref

友情提示：以下期刊信息可能会有更新，仅供参考，请在投稿前自行登录期刊官网仔细核实。

期刊名

DRUG DELIVERY

DRUG DELIV

ISSN / eISSN

1071-7544 / 1521-0464

目标和范围

Drug Delivery is an open access journal serving the academic and industrial communities with peer reviewed coverage of basic research, development, and application principles of drug delivery and targeting at molecular, cellular, and higher levels. Topics covered include all delivery systems including oral, pulmonary, nasal, parenteral and transdermal, and modes of entry such as controlled release systems; microcapsules, liposomes, vesicles, and macromolecular conjugates; antibody targeting; protein/peptide delivery; DNA, oligonucleotide and siRNA delivery. Papers on drug dosage forms and their optimization will not be considered unless they directly relate to the original drug delivery issues. Published articles present original research and critical reviews.

研究方向

药学

CiteScore

8.70

查看趋势图

CiteScore 学科排名

类别	分区	排名
Pharmacology, Toxicology and Pharmaceutics - Pharmaceutical Science	Q1	#26/171

Web of Science 核心合集

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

类别 (Journal Citation Reports 2023)	分区
PHARMACOLOGY & PHARMACY - SCIE	Q1

H-index

出版国家或地区

UNITED STATES

出版商

Informa Healthcare

出版周期

Bimonthly

出版年份

1993

年文章数

267

Open Access

YES

通讯方式

TAYLOR & FRANCIS INC, 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, USA, PA, 19106

同领域相关热门期刊
近期发表文章

Identifying a predictive relationship between maximal flow rate and viscosity for subcutaneous administration of macromolecules with recombinant human hyaluronidase PH20 in a miniature pig model: (2023) Robert J. Connor, Renee Clift, David W. Kang

Advances in smart delivery of magnetic field-targeted drugs in cardiovascular diseases: (2023) Xinyu Wang, Ruru Bai

Novel tetrahydrocurcumin integrated mucoadhesive nanocomposite κ-carrageenan/xanthan gum sponges: a strategy for effective local treatment of oral cancerous and precancerous lesions: (2023) Shimaa A. Elbanna, Heba M. K. Ebada, Ossama Y. Abdallah, Marwa M. Essawy, Hend M. Abdelhamid, Hebatallah S. Barakat

Kartogenin delivery systems for biomedical therapeutics and regenerative medicine: (2023) Peixing Chen, Xiaoling Liao

Metformin HCl-loaded transethosomal gel; development, characterization, and antidiabetic potential evaluation in the diabetes-induced rat model: (2023) Kainat Nousheen, Fakhar Ud Din, Humzah Jamshaid, Rabia Afza, Saif Ullah Khan, Maimoona Malik, Zakir Ali, Sibgha Batool, Alam Zeb, Abid Mehmood Yousaf,...

Topically applied pH-responsive nanogels for alkyl radical-based therapy against psoriasiform hyperplasia: (2023) G.R. Nirmal, Chia-Chih Liao, Zih-Chan Lin, Abdullah Alshetaili, Erica Hwang, Shih-Chun Yang, Jia-You Fang

Oral delivery of nerolidol alleviates cyclophosphamide-induced renal inflammation, apoptosis, and fibrosis via modulation of NF-κB/cleaved caspase-3/TGF-β signaling molecules: (2023) Ashif Iqubal, Abul Kalam Najmi, Shadab Md, Huda Mohammed Alkreathy, Javed Ali, Mansoor Ali Syed, Syed Ehtaishamul Haque

Novel nano-carriers with N-formylmethionyl-leucyl-phenylalanine-modified liposomes improve effects of C16-angiopoietin 1 in acute animal model of multiple sclerosis: (2023) Xiao-Xiao Fu, Han Qu, Jing Wang, Hua-Ying Cai, Hong Jiang, Hao-Hao Chen, Shu Han

Sustained delivery of triamcinolone acetonide from a thermosensitive microemulsion gel system for the treatment of sensorineural hearing loss: (2023) Thu Nhan Nguyen, So-Yeol Yoo, Warisraporn Tangchang, Jae-Young Lee, Hwa-Young Son, Jeong-Sook Park

Development of canagliflozin nanocrystals sublingual tablets in the presence of sodium caprate permeability enhancer: formulation optimization, characterization, in-vitro, in silico, and in-vivo study: (2023) Sammar Fathy Elhabal, Mohamed A El-Nabarawi, Nashwa Abdelaal, Mohamed Fathi Mohamed Elrefai, Shrouk A. Ghaffar, Mohamed Mansour Khalifa, Passant M. Mo...

认证评论

注：认证评论选取于全球各个学术评论平台和社交媒体。

First submission in mid-October was rejected due to a missing data statement. I submitted the manuscript using my own account, thinking that I would be notified within my account. However, after waiting for almost a month, I realized that I needed to log in to the corresponding author's account. I resubmitted the manuscript at the end of November, received major revisions in late December, resubmitted at the end of January, and it was accepted on February 1st. The current status is "Awaiting Assignment to Batch". I would like to know how long it usually takes for the editor to provide proofs for modifications in this status.

2022-02-03

Oh no, I have also been waiting for over two months and it still hasn't reached the editor's hands. I followed up once during this period, but the only update was the change in status time. I'm in a hurry to graduate, how did you finally handle it?

2023-07-06

查看所有评论

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now